These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Construction and application of retroviral vector carrying green fluorescent protein]. Wang H, Qian Q, Cao H, Wei L, Qu Z, Da W, Guo Y, Wu M. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Aug; 15(4):232-4. PubMed ID: 9691133 [Abstract] [Full Text] [Related]
3. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers. Xu L, Tsuji K, Mostowski H, Otsu M, Candotti F, Rosenberg AS. J Virol Methods; 2004 Jun 01; 118(1):61-7. PubMed ID: 15158069 [Abstract] [Full Text] [Related]
5. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site. Byun J, Kim JM, Robbins PD, Kim S. Gene Ther; 1998 Oct 01; 5(10):1441-4. PubMed ID: 9930351 [Abstract] [Full Text] [Related]
6. Construction of new retroviral producer cells from adenoviral and retroviral vectors. Lin X. Gene Ther; 1998 Sep 01; 5(9):1251-8. PubMed ID: 9930327 [Abstract] [Full Text] [Related]
8. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Sastry L, Johnson T, Hobson MJ, Smucker B, Cornetta K. Gene Ther; 2002 Sep 01; 9(17):1155-62. PubMed ID: 12170379 [Abstract] [Full Text] [Related]
9. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells]. Zhang RP, Yun L, Peng L, Lu B, Zhou Q, Wang H, Guo YJ. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul 01; 22(4):420-2, 426. PubMed ID: 16805997 [Abstract] [Full Text] [Related]
10. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and beta-galactosidase or green fluorescent protein. Aran JM, Gottesman MM, Pastan I. Cancer Gene Ther; 1998 Jul 01; 5(4):195-206. PubMed ID: 9694071 [Abstract] [Full Text] [Related]
12. Reliable generation of stable high titer producer cell lines for gene therapy. Rattmann I, Kleff V, Feldmann A, Ludwig C, Sorg UR, Opalka B, Moritz T, Flasshove M. Intervirology; 2007 Jul 01; 50(3):197-203. PubMed ID: 17283445 [Abstract] [Full Text] [Related]
13. Adenovirus vectors as transcomplementing templates for the production of replication defective retroviral vectors. Ramsey WJ, Caplen NJ, Li Q, Higginbotham JN, Shah M, Blaese RM. Biochem Biophys Res Commun; 1998 May 29; 246(3):912-9. PubMed ID: 9618311 [Abstract] [Full Text] [Related]
16. Simultaneous flow cytometric analyses of enhanced green and yellow fluorescent proteins and cell surface antigens in doubly transduced immature hematopoietic cell populations. Stull RA, Hyun WC, Pallavicini MG. Cytometry; 2000 Jun 01; 40(2):126-34. PubMed ID: 10805932 [Abstract] [Full Text] [Related]
17. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange. Coroadinha AS, Schucht R, Gama-Norton L, Wirth D, Hauser H, Carrondo MJ. J Biotechnol; 2006 Jul 13; 124(2):457-68. PubMed ID: 16529836 [Abstract] [Full Text] [Related]
18. Removal of selectable marker gene from fibroblast cells in transgenic cloned cattle by transient expression of Cre recombinase and subsequent effects on recloned embryo development. Wang S, Sun X, Ding F, Zhang K, Zhao R, Li S, Li R, Tang B, Zhang L, Liu Y, Li J, Gao F, Wang H, Wang L, Dai Y, Li N. Theriogenology; 2009 Sep 01; 72(4):535-41. PubMed ID: 19515406 [Abstract] [Full Text] [Related]
19. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage. Hanazono Y, Yu JM, Dunbar CE, Emmons RV. Hum Gene Ther; 1997 Jul 20; 8(11):1313-9. PubMed ID: 9295126 [Abstract] [Full Text] [Related]
20. Sorting vector producer cells for high transgene expression increases retroviral titer. Beaudoin EL, Bais AJ, Junghans RP. J Virol Methods; 2008 Mar 20; 148(1-2):253-9. PubMed ID: 18249448 [Abstract] [Full Text] [Related] Page: [Next] [New Search]